Monday, May 16, 2016

BRIEF-Galmed Pharmaceuticals posts Q1 loss of $0.36 per share

* Galmed Pharmaceuticals reports first quarter 2016

financial results and provides business update

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)